TMC PULSE

Vol. 36 / No.7 V2

Issue link: https://tmcpulse.uberflip.com/i/308706

Contents of this Issue

Navigation

Page 35 of 43

t m c » p u l s e | m a y 7, 2 0 1 4 34 ACCOLAdES Randolph evans, M.d., clinical professor of neurology at Baylor College of Medicine, has received the Lifetime Achievement Award from the 750-member Texas Neurological Society in Austin, Texas. Evans is board-certified in Neurology and subspecialty certified in Headache Medicine and a Fellow of the American Academy of Neurology, the American Headache Society and the Texas Neurological Society. He specializes in headache medicine and has published numerous books and articles and gives lectures on the topic. caRIne M. Feyten, ph.d., has been named chancellor and president of Texas Woman's University (TWU) by the board of regents. Feyten holds a Ph.D. in Interdisciplinary Education, Second Language Acquisition from the University of South Florida, and is fluent in five languages. Feyten joins TWU after serving as dean of the College of Education, Health and Society at Miami University in Oxford, Ohio, since 2006. She will begin her tenure as TWU's second chancellor and 11th presi- dent on July 1. She succeeds Dr. Ann Stuart, who is retiring after 14 years as chancellor and president of the university. JeFF gentRy assumed the role of chief financial officer for DePelchin Children's Center. He replaces Peggy Pugh, who is retiring after 13 years in the position. Gentry will be responsible for all financial administration, risk management and treasury oper- ations with leadership over the accounting, informa- tion technology, facilities and plant management and clinical services departments. He has served in various leadership roles for the National Multiple Sclerosis Society over the past eight years and was recently the National CFO for the Society located in New York City. yohannes ghebReMaRIaM, ph.d., assistant member at the Houston Methodist Research Institute, Department of Cardiovascular Sciences, has been awarded a 5-year K-grant from the National Heart, Lung, and Blood Institute to investigate the therapeutic potential of a generic drug for the treatment of Idiopathic Lung Fibrosis (IPF). Ghebremariam and his team will use in vitro and in vivo models to understand the mechanism by which a commonly used generic drug might regulate the disease process in IPF, a rare but deadly lung disease. Ghebremariam has been training with Dr. John Cooke at Stanford University and jointly established the Department of Cardiovascular Sciences at the Houston Methodist Research Institute in 2013. John t. gReeR has been named director of development for Texas Heart Institute. A 25-year veteran in the fundraising field, Greer comes to Texas Heart Institute from the University of Texas School of Dentistry at Houston, where he served for more than seven years as executive director of devel- opment. Previously, he fulfilled roles in the field of development at Rice University, the Leukemia Society of America, and CHRISTUS Foundation for Healthcare. baha M. sIbaI, M.d., professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at The University of Texas Health Science Center at Houston (UTHealth) Medical School, has been awarded the Lifetime Achievement Award by the Society for Maternal-Fetal Medicine. Sibai directs UTHealth's maternal-fetal medicine fel- lowship program and has active clinical practices at Memorial Hermann-Texas Medical Center and Lyndon B. Johnson Hospital, part of Harris Health System. He is a founding member and past presi- dent of the North American Society for the Study of Hypertension in Pregnancy and past presi- dent of the International Society for the Study of Hypertension and Pregnancy. haRdeep sIngh, M.d., M.p.h., has been named a recipient of the prestigious Presidential Early Career Award for Scientists and Engineers (PECASE). Singh is the chief of the Health Policy, Quality & Informatics program at the Houston VA Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety, and associate professor of medicine at Baylor College of Medicine. He will receive the award from President Obama at a White House ceremony later this year. PECASE awards are the highest honor bestowed by the United States government on science and engineering professionals in the early stages of their independent research careers. huda zoghbI, M.d., founding director of the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital and profes- sor of molecular and human genetics at Baylor College of Medicine, is the winner of the Edward M. Scolnick Prize in Neuroscience. It is awarded annu- ally by the McGovern Institute for Brain Research in Cambridge, Mass., to recognize outstanding advances in the field of neuroscience. Zoghbi is perhaps best known for her pioneering work on Rett syndrome, a genetic neurological disease that affects young girls.

Articles in this issue

view archives of TMC PULSE - Vol. 36 / No.7 V2